Beauty device maker Classys will proceed with its merger with Ilooda as scheduled despite exceeding the size of the stock purchase right.
In a strategic move to solidify its position as a global leader in the medical aesthetics industry, Classys has announced the acquisition of Ilooda, a renowned innovator in laser-based medical devices. This acquisition brings a range of advanced laser technologies under Classys’ expanding portfolio, including REEPOT, Secret DUO, Curas Hybrid, Pento Long Pulsed Laser, and Veloce BBL.

Advancing Innovation in Medical Aesthetics
With this acquisition, Classys continues its mission to offer state-of-the-art aesthetic and medical treatment solutions. Ilooda’s expertise in laser technology, combined with Classys’ global reach and innovation-driven approach, will enhance the company’s market influence and reinforce its commitment to excellence in dermatology and aesthetic medicine.
Elevating Clinical Excellence with Advanced Intelligence
With this acquisition, Classys continues its mission to offer state-of-the-art aesthetic and medical treatment solutions. Ilooda’s expertise in laser technology, combined with Classys’ global reach and innovation-driven approach, will enhance the company’s market influence and reinforce its commitment to excellence in dermatology and aesthetic medicine.
Expanding Product Portfolio for Superior Technology
The newly integrated products are expected to redefine treatment standards:
Curas Hybrid Laser – Designed for Melasma, pigmentation treatment, and precise skin rejuvenation.
Secret DUO – A cutting-edge Microneedle RF and laser combination system with Fractional 1540nm Er:glass laser for non-invasive skin tightening.
REEPOT Laser – World’s first targeted laser with super cooling technology to reduce vascular lesions
Pento Long Pulsed Laser – Targets vascular and pigmented lesions with high precision.
Veloce BBL – Delivers broadband light technology for advanced skin rejuvenation.
Â
Commitment to Research, Development, and Excellence
By incorporating Ilooda’s innovative laser technologies, Classys strengthens its commitment to providing premium, clinically proven solutions that deliver superior patient outcomes. The company aims to leverage this acquisition to expand its research and development efforts, ensuring continuous advancements in medical aesthetics.
Strengthening Classys’ Global Footprint in Aesthetic Technology
As Classys integrates Ilooda’s expertise and product line into its operations, the company remains dedicated to advancing next-generation aesthetic solutions that meet the evolving demands of practitioners and patients worldwide. With a strong emphasis on quality, efficacy, and patient satisfaction, this acquisition further cements Classys’ role as a driving force in modern aesthetic and dermatological care.
For practitioners, dermatologists, and patients, Classys’ expanded portfolio represents a new era of cutting-edge aesthetic solutions that combine innovation, safety, and outstanding results.
Source: Article